Literature DB >> 8694894

The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat.

I M Dick1, A St John, S Heal, R L Prince.   

Abstract

The oophorectomized (OOX) rat has been proposed as a good model of postmenopausal osteoporosis in women. The aim of this study was to compare the effect of OOX in 6-month-old rats to the effects of menopause in women with respect to bone mass, the renal handling of calcium and phosphorus, and calcitropic hormones. To more closely replicate the human situation the rats were pair fed a 0.1% calcium diet. Thirty four, 6-month-old rats were randomized to sham operation or OOX. Whole body and regional bone density was performed at baseline and 6 weeks postoperation. Blood and 24-hour urine samples were obtained at baseline, 1, 3, and 6 weeks and assayed for various biochemical variables, parathyroid hormone (PTH), and calcitriol. The OOX rats lost significantly more bone than the sham-operated rats (change in global bone mineral density, sham -1.7 +/- 2.0%, OOX -3.9 +/- 2.6%, P < 0.001). In the OOX animals, an increase in the 24-hour urine calcium was observed at 1 and 3 weeks, which had returned to sham-operated levels by 6 weeks. In the whole group, the increase in urine calcium at 1 week was negatively correlated with the change in bone mass at 6 weeks (r = -0.39, P = 0. 029). OOX resulted in an increased filtered load of calcium and phosphorus. There was an increase in the maximal renal tubular reabsorption of phosphorus (TmP-GFR) but no clear change in renal calcium handling. Neither calcitriol nor parathyroid hormone showed a significant change as a result of OOX. As in postmenopausal women, following oophorectomy in the rat, there was significant generalized bone loss and a negative calcium balance. This was associated with an initial rise in urine calcium due to a rise in the filtered calcium load; plasma phosphorus and TmP-GFR also rose. The rat model may differ from postmenopausal bone loss in that the initial rise in urine calcium was not present at later time points as occurs in natural menopause in women. Calcitropic hormone levels did not change. This study has shown that the 6-month-old OOX rat fed a 0.1% calcium diet has many similarities of calcium and phosphorus homeostasis to that seen at menopause in women.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8694894     DOI: 10.1007/s002239900105

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  20 in total

1.  The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Authors:  S Adami; D Gatti; F Bertoldo; M Rossini; A Fratta-Pasini; N Zamberlan; E Facci; V Lo Cascio
Journal:  Osteoporos Int       Date:  1992-07       Impact factor: 4.507

2.  Evidence for a renal calcium leak in postmenopausal women.

Authors:  B E Nordin; A G Need; H A Morris; M Horowitz; W G Robertson
Journal:  J Clin Endocrinol Metab       Date:  1991-02       Impact factor: 5.958

3.  Improved method for calculating calcium fractions in plasma: reference values and effect of menopause.

Authors:  B E Nordin; A G Need; T F Hartley; J C Philcox; M Wilcox; D W Thomas
Journal:  Clin Chem       Date:  1989-01       Impact factor: 8.327

4.  Assay of circulating 1,25-dihydroxyvitamin D involving a novel single-cartridge extraction and purification procedure.

Authors:  B W Hollis
Journal:  Clin Chem       Date:  1986-11       Impact factor: 8.327

5.  Changes in vitamin D metabolism during natural and medical menopause.

Authors:  D Hartwell; B J Riis; C Christiansen
Journal:  J Clin Endocrinol Metab       Date:  1990-07       Impact factor: 5.958

6.  Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone-replacement therapy.

Authors:  R L Prince; M Smith; I M Dick; R I Price; P G Webb; N K Henderson; M M Harris
Journal:  N Engl J Med       Date:  1991-10-24       Impact factor: 91.245

7.  The effects of menopause and age on calcitropic hormones: a cross-sectional study of 655 healthy women aged 35 to 90.

Authors:  R L Prince; I Dick; A Devine; R I Price; D H Gutteridge; D Kerr; A Criddle; P Garcia-Webb; A St John
Journal:  J Bone Miner Res       Date:  1995-06       Impact factor: 6.741

8.  Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age.

Authors:  P J Elders; J C Netelenbos; P Lips; F C van Ginkel; E Khoe; O R Leeuwenkamp; W H Hackeng; P F van der Stelt
Journal:  J Clin Endocrinol Metab       Date:  1991-09       Impact factor: 5.958

9.  Effect of calcium supplementation on bone loss in postmenopausal women.

Authors:  I R Reid; R W Ames; M C Evans; G D Gamble; S J Sharpe
Journal:  N Engl J Med       Date:  1993-02-18       Impact factor: 91.245

10.  Short-term changes in histomorphometric and biochemical turnover markers and bone mineral density in estrogen-and/or dietary calcium-deficient rats.

Authors:  V Shen; R Birchman; R Xu; R Lindsay; D W Dempster
Journal:  Bone       Date:  1995-01       Impact factor: 4.398

View more
  3 in total

1.  Oestrogen effects on calcium membrane transport: a new view of the inter-relationship between oestrogen deficiency and age-related osteoporosis.

Authors:  R L Prince; I Dick
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Effects of the SERM raloxifene on calcium and phosphate metabolism in healthy middle-aged men.

Authors:  Brigitte Uebelhart; François Herrmann; René Rizzoli
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

Review 3.  Ovariectomized rat model of osteoporosis: a practical guide.

Authors:  Nasibeh Yousefzadeh; Khosrow Kashfi; Sajad Jeddi; Asghar Ghasemi
Journal:  EXCLI J       Date:  2020-01-10       Impact factor: 4.068

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.